Calcium electroporation induces tumor eradication, long-lasting immunity and cytokine responses in the CT26 colon cancer mouse model

References

• Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J, Jr, Mir LM. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 1993; 72:3694-700; PMID:7504576; https://doi.org/10.1002/1097-0142(19931215)72:12<3694::AID-CNCR2820721222>3.0.CO;2-2
   PubMed Web of Science ®Google Scholar
• Matthiessen LW, Chalmers RL, Sainsbury DC, Veeramani S, Kessell G, Humphreys AC, Bond JE, Muir T, Gehl J. Management of cutaneous metastases using electrochemotherapy. Acta Oncol 2011; 50:621-9; PMID:21574833; https://doi.org/10.3109/0284186X.2011.573626
   PubMed Web of Science ®Google Scholar
• Matthiessen LW, Johannesen HH, Hendel HW, Moss T, Kamby C, Gehl J. Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial. Acta Oncol 2012; 51:713-21; PMID:22731832; https://doi.org/10.3109/0284186X.2012.685524
   PubMed Web of Science ®Google Scholar
• Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, Billard V, Geertsen PF, Larkin JO, Miklavcic D et al. Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Ejc Supplements 2006; 4:3-13; https://doi.org/10.1016/j.ejcsup.2006.08.002
   Google Scholar
• Campana LG, Mocellin S, Basso M, Puccetti O, De Salvo GL, Chiarion-Sileni V, Vecchiato A, Corti L, Rossi CR, Nitti D. Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients. Ann Surg Oncol 2009; 16:191-9; PMID:18987914; https://doi.org/10.1245/s10434-008-0204-8
   PubMed Web of Science ®Google Scholar
• Campana LG, Valpione S, Falci C, Mocellin S, Basso M, Corti L, Balestrieri N, Marchet A, Rossi CR. The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study. Breast Cancer Res Treat 2012; 134:1169-78; PMID:22821399; https://doi.org/10.1007/s10549-012-2095-4
   PubMed Web of Science ®Google Scholar
• Campana LG, Valpione S, Mocellin S, Sundararajan R, Granziera E, Sartore L, Chiarion-Sileni V, Rossi CR. Electrochemotherapy for disseminated superficial metastases from malignant melanoma. Br J Surg 2012; 99:821-30; PMID:22508342; https://doi.org/10.1002/bjs.8749
   PubMed Web of Science ®Google Scholar
• Curatolo P, Quaglino P, Marenco F, Mancini M, Nardo T, Mortera C, Rotunno R, Calvieri S, Bernengo MG. Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: a two-center prospective phase II trial. Ann Surg Oncol 2012; 19:192-8; PMID:21822561; https://doi.org/10.1245/s10434-011-1860-7
   PubMed Web of Science ®Google Scholar
• Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, DeConti RC, Gilbert RA, Glass LF. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 1998; 83:148-57; PMID:9655305; https://doi.org/10.1002/(SICI)1097-0142(19980701)83:1<148::AID-CNCR20>3.0.CO;2-W
   PubMed Web of Science ®Google Scholar
• Kis E, Olah J, Ocsai H, Baltas E, Gyulai R, Kemeny L, Horvath AR. Electrochemotherapy of cutaneous metastases of melanoma–a case series study and systematic review of the evidence. Dermatol Surg 2011; 37:816-24; PMID:21605245; https://doi.org/10.1111/j.1524-4725.2011.01951.x
   PubMed Web of Science ®Google Scholar
• Larkin JO, Collins CG, Aarons S, Tangney M, Whelan M, O'Reily S, Breathnach O, Soden DM, O'Sullivan GC. Electrochemotherapy – aspects of preclinical development and early clinical experience. Ann Surgery 2007; 245:469-79; PMID:17435555; https://doi.org/10.1097/01.sla.0000250419.36053.33
   PubMed Web of Science ®Google Scholar
• Mir LM, Glass LF, Sersa G, Teissie J, Domenge C, Miklavcic D, Jaroszeski MJ, Orlowski S, Reintgen DS, Rudolf Z et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 1998; 77:2336-42; PMID:9649155; https://doi.org/10.1038/bjc.1998.388
   PubMed Web of Science ®Google Scholar
• Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003; 4:517-29; PMID:12838335; https://doi.org/10.1038/nrm1155
   PubMed Web of Science ®Google Scholar
• Frandsen SK, Gissel H, Hojman P, Tramm T, Eriksen J, Gehl J. Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. Cancer Res 2012; 72:1336-41; PMID:22282658; https://doi.org/10.1158/0008-5472.CAN-11-3782
   PubMed Web of Science ®Google Scholar
• Garg AD, Nowis D, Golab J, Vandenabeele P, Krysko DV, Agostinis P. Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim Biophys Acta 2010; 1805:53-71; PMID:19720113; https://doi.org/10.1016/j.bbcan.2009.08.003
   PubMed Web of Science ®Google Scholar
• Calvet CY, Famin D, Andre FM, Mir LM. Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells. Oncoimmunology 2014; 3:e28131; PMID:25083316; https://doi.org/10.4161/onci.28131
   PubMed Web of Science ®Google Scholar
• Andersen MH, Gehl J, Reker S, Pedersen LO, Becker JC, Geertsen P, thor Straten P. Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration. Semin Cancer Biol 2003; 13:449-59; PMID:15001164; https://doi.org/10.1016/j.semcancer.2003.09.009
   PubMed Web of Science ®Google Scholar
• Spratt DE, Gordon Spratt EA, Wu S, DeRosa A, Lee NY, Lacouture ME, Barker CA. Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis. J Clin Oncol 2014; 32:3144-55; PMID:25154827; https://doi.org/10.1200/JCO.2014.55.4634
   PubMed Web of Science ®Google Scholar
• Kuriyama S, Mitoro A, Tsujinoue H, Toyokawa Y, Nakatani T, Yoshiji H, Tsujimoto T, Okuda H, Nagao S, Fukui H. Electrochemotherapy can eradicate established colorectal carcinoma and leaves a systemic protective memory in mice. Int J Oncol 2000; 16:979-85; PMID:10762634; https://doi.org/10.3892/ijo.16.5.979
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Gunji Y, Matsubara H, Shimada H, Uesato M, Suzuki T, Kouzu T, Ochiai T. Possible involvement of antitumor immunity in the eradication of colon 26 induced by low-voltage electrochemotherapy with bleomycin. Surg Today 2003; 33:39-44; PMID:12560905; https://doi.org/10.1007/s005950300006
   PubMed Web of Science ®Google Scholar
• Mir LM, Roth C, Orlowski S, Quintin-Colonna F, Fradelizi D, Belehradek J, Jr, Kourilsky P. Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Immunother Emphasis Tumor Immunol 1995; 17:30-8; PMID:7537154
   PubMed Web of Science ®Google Scholar
• Cemazar M, Ambrozic Avgustin J, Pavlin D, Sersa G, Poli A, Krhac Levacic A, Tesic N, Lampreht Tratar U, Rak M, Tozon N. Efficacy and safety of electrochemotherapy combined with peritumoral IL-12 gene electrotransfer of canine mast cell tumours. Vet Comp Oncol 2016; PMID:26840222; https://doi.org/10.1111/vco.12208
   PubMed Web of Science ®Google Scholar
• Heppt MV, Eigentler TK, Kahler KC, Herbst RA, Goppner D, Gambichler T, Ulrich J, Dippel E, Loquai C, Schell B et al. Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis. Cancer Immunol Immunother 2016; 65:951-9; PMID:27294607; https://doi.org/10.1007/s00262-016-1856-z
   PubMed Web of Science ®Google Scholar
• Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, Munster PN, Sullivan DM, Ugen KE, Messina JL et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008; 26:5896-903; PMID:19029422; https://doi.org/10.1200/JCO.2007.15.6794
   PubMed Web of Science ®Google Scholar
• Larkin JO, Casey GD, Tangney M, Cashman J, Collins CG, Soden DM, O'Sullivan GC. Effective tumor treatment using optimized ultrasound-mediated delivery of bleomycin. Ultrasound Med Biol 2008; 34:406-13; PMID:17988788; https://doi.org/10.1016/j.ultrasmedbio.2007.09.005
   PubMed Web of Science ®Google Scholar
• Mir LM, Belehradek M, Domenge C, Orlowski S, Poddevin B, Belehradek J, Jr, Schwaab G, Luboinski B, Paoletti C. Electrochemotherapy, a new antitumor treatment: first clinical trial. C R Acad Sci III 1991; 313:613-8; PMID:1723647
   PubMed Web of Science ®Google Scholar
• Falk H, Lambaa S, Johannessen HH, Wooler G, Venzo A, Gehl J. Electrochemotherapy and calcium electroporation inducing a systemic immune response with local and distant remission of tumors in a patient with malignant melanoma – a case report. Acta Oncol; 2017; [Published online]; https://doi.org/10.1080/0284186X.2017.1290274
   PubMed Web of Science ®Google Scholar
• Di Gennaro P, Gerlini G, Urso C, Sestini S, Brandani P, Pimpinelli N, Borgognoni L. CD4+FOXP3+ T regulatory cells decrease and CD3+CD8+ T cells recruitment in TILs from melanoma metastases after electrochemotherapy. Clin Exp Metastasis 2016; 33(8):787-98
   PubMed Web of Science ®Google Scholar
• Bugaut H, Bruchard M, Berger H, Derangere V, Odoul L, Euvrard R, Ladoire S, Chalmin F, Végran F, Rébé C et al. Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells. PLoS One 2013; 8:e65181; PMID:23762310; https://doi.org/10.1371/journal.pone.0065181
   PubMed Web of Science ®Google Scholar
• Frandsen SK, Gibot L, Madi M, Gehl J, Rols MP. Calcium electroporation: evidence for differential effects in normal and malignant cell lines, evaluated in a 3D spheroid model. PLoS One 2015; 10:e0144028; PMID:26633834; https://doi.org/10.1371/journal.pone.0144028
   PubMed Web of Science ®Google Scholar
• Hansen EL, Sozer EB, Romeo S, Frandsen SK, Vernier PT, Gehl J. Dose-dependent ATP depletion and cancer cell death following calcium electroporation, relative effect of calcium concentration and electric field strength. PLoS One 2015; 10:e0122973; PMID:25853661; https://doi.org/10.1371/journal.pone.0122973
   PubMed Web of Science ®Google Scholar
• Raucci A, Palumbo R, Bianchi ME. HMGB1: a signal of necrosis. Autoimmunity 2007; 40:285-9; PMID:17516211; https://doi.org/10.1080/08916930701356978
   PubMed Web of Science ®Google Scholar